relapsing forms of multiple sclerosis
GPTKB entity
Statements (59)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:psychologist
|
gptkbp:bfsLayer |
4
|
gptkbp:bfsParent |
gptkb:Ocrevus
|
gptkbp:affects |
central nervous system
|
gptkbp:can_lead_to |
disability
cognitive impairment mobility issues relapses |
gptkbp:caused_by |
autoimmune response
|
gptkbp:has_achievements |
gptkb:historical_event
secondary infections |
gptkbp:has_style |
gptkb:relapsing-remitting_multiple_sclerosis
gptkb:secondary_progressive_multiple_sclerosis |
https://www.w3.org/2000/01/rdf-schema#label |
relapsing forms of multiple sclerosis
|
gptkbp:impact |
quality of life
|
gptkbp:is_affected_by |
stress
temperature changes |
gptkbp:is_associated_with |
rehabilitation programs
chronic pain inflammation demyelination fatigue management strategies |
gptkbp:is_characterized_by |
periods of remission
exacerbations periods of relapse remissions |
gptkbp:is_documented_in |
gptkb:municipality
gptkb:academic_journal |
gptkbp:is_monitored_by |
regular check-ups
neurological assessments |
gptkbp:is_often_depicted_as |
psychological conditions
other neurological disorders |
gptkbp:is_often_used_in |
gptkb:philosopher
young adults |
gptkbp:is_part_of |
multiple sclerosis spectrum disorders
|
gptkbp:is_related_to |
environmental factors
genetic factors |
gptkbp:is_studied_in |
clinical trials
new treatment options long-term outcomes |
gptkbp:is_supported_by |
research funding
patient advocacy groups |
gptkbp:managed_by |
physical therapy
lifestyle changes symptomatic treatment primary care physicians neurologists |
gptkbp:social_responsibility |
gptkb:MRI
variable neurological examination |
gptkbp:symptoms |
fatigue
vision problems weakness numbness cognitive changes |
gptkbp:treatment |
gptkb:vaccine
corticosteroids plasma exchange disease-modifying therapies |